⌘K

Login Start Free

Home/Filings/4/0001607062-16-000653

4//SEC Filing

GENEREX BIOTECHNOLOGY CORP 4

Accession 0001607062-16-000653

CIK 0001059784operating

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:08 PM ET

Size

13.0 KB

Accession

0001607062-16-000653

Insider Transaction Report

Form 4

Period: 2016-02-09

GENEREX BIOTECHNOLOGY CORPGNBT

EVP & General Counsel

Transactions

Exercise/Conversion
Common Stock
2016-02-09$0.00/sh+14,890,033$14,890→ 10,442,992 total
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−1,457,195→ 0 total
Exercise: $0.00From: 2012-06-19Exp: 2017-06-19→ Common Stock (1,457,195 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−5,143,787→ 0 total
Exercise: $0.00From: 2013-04-01Exp: 2018-04-01→ Common Stock (5,143,787 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−1,587,300→ 0 total
Exercise: $0.00From: 2013-06-06Exp: 2018-06-06→ Common Stock (1,587,300 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09+4,447,111→ 4,447,111 total
Exercise: $0.00From: 2016-02-09Exp: 2020-10-26→ Common Stock (4,447,111 underlying)

Documents

1 file

4
fletcher021216form4.xmlPrimary
FORM 4

Issuer

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001059784

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 4:08 PM ET
Size: 13.0 KB

View on SEC.gov